Filing Details
Bone Biologics Corp (NASDAQ:BBLG) filed a Form 8-K with the Securities and Exchange Commission on July 09, 2026, disclosing a material event.
8k filedNASDAQ:BBLG
Bone Biologics Corp (BBLG) Reports Material Event to SEC
Filing Details Bone Biologics Corp (NASDAQ:BBLG) filed a Form 8-K with the Securities and Exchange Commission on July 09, 2026, disclosing a material event. Market Context Bone…
Market Context
Bone Biologics Corp's stock currently trades at $1.38 with a market capitalization of $3.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Bone Biologics Corp's stock.
All SEC filings for Bone Biologics Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BBLG Stock Page
Frequently Asked Questions
Where can I read BBLG's SEC filings?
Browse all filings on our BBLG SEC filings page.
What types of SEC filings does Bone Biologics Corp file?
Public companies like Bone Biologics Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
